Overview

The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL

Status:
Withdrawn

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine what effect teriparatide will have on vascular (blood vessel) compliance and osteoprotegerin (bone fluid)and RANKL levels (bone cells).

Phase:

N/A

Details

Lead Sponsor:

Leland Graves III, MD

Collaborator:

University of Kansas

Treatments:

Teriparatide